Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biopharmaceutical drug
|
| gptkbp:clinicalTrialPhase |
Phase I/II
|
| gptkbp:developedBy |
gptkb:INmune_Bio,_Inc.
|
| https://www.w3.org/2000/01/rdf-schema#label |
INmune-ALPHA
|
| gptkbp:intendedUse |
treatment of COVID-19
|
| gptkbp:mechanismOfAction |
modulation of innate immune response
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:cytokine_storm
COVID-19 pneumonia |
| gptkbp:bfsParent |
gptkb:INmune_Bio
|
| gptkbp:bfsLayer |
7
|